This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Id4pharma, LLC. Active years: 2017-2023.
Company Filing History:
Years Active: 2017-2023
Title: Garson David Roodman: Innovator in Chemical Inhibitors
Introduction
Garson David Roodman is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medical research, particularly in the development of chemical inhibitors for treating diseases.
Latest Patents
Roodman holds 2 patents, with his latest inventions focusing on the p62-ZZ chemical inhibitor. This method is designed for treating p62-mediated diseases, such as multiple myeloma. The approach involves administering a therapeutically effective amount of at least one p62-ZZ inhibitor compound to the subject.
Career Highlights
Roodman is associated with Id4pharma, LLC, where he continues to advance his research and innovations. His work has the potential to impact the treatment of serious medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Roodman has collaborated with esteemed colleagues, including Xiang-Qun Xie and Noriyoshi Kurihara. These partnerships enhance the research efforts and contribute to the development of effective treatments.
Conclusion
Garson David Roodman is a prominent figure in the field of chemical inhibitors, with a focus on innovative solutions for treating diseases. His contributions are paving the way for advancements in medical treatments.